Therefore, identifying effective biomarkers can facilitate the differential diagnosis of SIADH and then contribute to the effective treatment of hyponatremia that connected with increased mortality (Corona et al., 2015).The differential proteins between the control and AVP infusion groups of this study may be used as candidate biomarkers to aid in diagnosing SIADH. Here, AVP is linked to inappropriate ADH syndrome.